ALS: Focus on purinergic signalling

Pharmacology and Therapeutics

Volumn 132, Issue 1, 2011, Pages 111-122

  Volonté, Cinzia ^a,b   Apolloni, Savina ^a,b   Carrì, Maria Teresa ^b,c   D'Ambrosi, Nadia ^a,b  

^a CNR   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Microglia; Motor neuron; Neurodegeneration; Neuroinflammation; P1 receptors; P2 receptors

Indexed keywords

ANTIINFLAMMATORY AGENT; ARIMOCLOMOL; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CISTANCHE TOTAL GLYCOSIDE; COMPLEMENTARY RNA; GSK 1223249; ISIS 333611; KNS 760704; MECOBALAMIN; MINOCYCLINE; MONOCLONAL ANTIBODY; NEUROPROTECTIVE AGENT; NP 001; OLESOXIME; PIOGLITAZONE; PLANT GLYCOSIDE; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PYRIMETHAMINE; RASAGILINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT VASCULOTROPIN; RETINOIC ACID; RILUZOLE; SNN 0029; TALAMPANEL; TAUROURSODEOXYCHOLIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AUTOLOGOUS STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; DRUG EFFICACY; DRUG MECHANISM; ELECTROMYOGRAM; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; FAMILIAL DISEASE; GENE MUTATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIVER INJURY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NEUROINFLAMMATION; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS; SYMPTOMATOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MOLECULAR TARGETED THERAPY; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION;

EID: 79960618487     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.06.002     Document Type: Review

References (129)

1. M.P. Abbracchio, G. Burnstock, A. Verkhratsky, and H. Zimmermann Purinergic signalling in the nervous system: An overview Trends Neurosci 32 2009 19 29
2. C. Agresti, M.E. Meomartini, S. Amadio, E. Ambrosiani, C. Volonté, and F. Aloisi ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: Involvement of metabotropic P2 receptors Brain Res Brain Res Rev 48 2005 157 165 (Pubitemid 40585746)
3. S. Amadio, S. Apolloni, N. D'Ambrosi, and C. Volonté Purinergic signalling at the plasma membrane: A multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis J Neurochem 116 2011 796 805
4. M. Andries, P. Van Damme, W. Robberecht, and L. Van Den Bosch Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis Neurobiol Dis 25 2007 8 16 (Pubitemid 44765212)
5. S.H. Appel, D.R. Beers, and J.S. Henkel T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: Are we listening? Trends Immunol 31 2010 7 17
6. R. Banerjee, R.L. Mosley, A.D. Reynolds, A. Dhar, V. Jackson-Lewis, and P.H. Gordon Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice PLoS One 3 2008 e2740
7. D.R. Beers, J.S. Henkel, Q. Xiao, W. Zhao, J. Wang, and A.A. Yen Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis Proc Natl Acad Sci U S A 103 2006 16021 16026 (Pubitemid 44657585)
8. D.R. Beers, J.S. Henkel, W. Zhao, J. Wang, and S.H. Appel CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS Proc Natl Acad Sci U S A 105 2008 15558 15563
9. M. Benatar Lost in translation: Treatment trials in the SOD1 mouse and in human ALS Neurobiol Dis 26 2007 1 13 (Pubitemid 46437445)
10. D. Blackburn, S. Sargsyan, P.N. Monk, and P.J. Shaw Astrocyte function and role in motor neuron disease: A future therapeutic target? Glia 57 2009 1251 1264
11. S. Boillée, K. Yamanaka, C.S. Lobsiger, N.G. Copeland, N.A. Jenkins, and G. Kassiotis Onset and progression in inherited ALS determined by motor neurons and microglia Science 312 2006 1389 1392 (Pubitemid 43839552)
12. W. Boston-Howes, E.O. Williams, A. Bogush, M. Scolere, P. Pasinelli, and D. Trotti Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosis Exp Neurol 213 2008 229 237
13. B.R. Brooks Managing amyotrophic lateral sclerosis: Slowing disease progression and improving patient quality of life Ann Neurol 65 2009 17 23
14. G. Burnstock Purinergic signalling and disorders of the central nervous system Nat Rev Drug Discov 7 2008 575 590 (Pubitemid 351927723)
15. G. Burnstock Unresolved issues and controversies in purinergic signalling J Physiol 586 2008 3307 3312 (Pubitemid 352005793)
16. G. Burnstock, and A. Verkhratsky Evolutionary origins of the purinergic signalling system Acta Physiol 195 2009 415 447
17. G. Burnstock, B.B. Fredholm, R.A. North, and A. Verkhratsky The birth and postnatal development of purinergic signalling Acta Physiol 195 2010 93 147
18. L. Capuron, and A.H. Miller Immune system to brain signaling: Neuropsychopharmacological implications Pharmacol Ther 130 2011 226 238
19. M.T. Carrì, G. Grignaschi, and C. Bendotti Targets in ALS: Designing multidrug therapies Trends Pharmacol Sci 27 2006 267 273
20. A. Casanovas, S. Hernández, O. Tarabal, J. Rosselló, and J.E. Esquerda Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis J Comp Neurol 506 2008 75 92 (Pubitemid 350293491)
21. B.C. Cheah, S. Vucic, A.V. Krishnan, and M.C. Kiernan Riluzole, neuroprotection and amyotrophic lateral sclerosis Curr Med Chem 17 2010 1942 1959
22. R. Chen, and N. Ende The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice J Med 31 2000 21 30 (Pubitemid 30614798)
23. A. Chiò, G. Benzi, M. Dossena, R. Mutani, and G. Mora Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players Brain 128 2005 472 476 (Pubitemid 40380183)
24. I.M. Chiu, H. Phatnani, M. Kuligowski, J.C. Tapia, M.A. Carrasco, and M. Zhang Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice Proc Natl Acad Sci U S A 106 2009 20960 20965
25. R. Ciccarelli, P. Ballerini, G. Sabatino, M.P. Rathbone, M. D'Onofrio, and F. Caciagli Involvement of astrocytes in purine-mediated reparative processes in the brain Int J Dev Neurosci 19 2001 395 414 (Pubitemid 32500336)
26. L.E. Cox, L. Ferraiuolo, E.F. Goodall, P.R. Heath, A. Higginbottom, and H. Mortiboys Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS) PLoS One 5 3 2010 e9872
27. M. Cozzolino, A. Ferri, and M.T. Carrì Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications Antioxid Redox Signal 10 2008 405 443
28. C. Crosio, C. Valle, A. Casciati, C. Iaccarino, and M.T. Carrì Astroglial inhibition of NF-kB does not ameliorate disease onset and progression in a mouse model for Amyotrophic Lateral Sclerosis (ALS) PLoS One 6 3 2011 e17187
29. M.E. Cudkowicz, J. Katz, D.H. Moore, G. O'Neill, J.D. Glass, and H. Mitsumoto Toward more efficient clinical trials for amyotrophic lateral sclerosis Amyotroph Lateral Scler 11 2010 259 265
30. N. D'Ambrosi, M. Iafrate, F. Vacca, S. Amadio, A. Tozzi, N.B. Mercuri, and C. Volonté Purinergic signal 2 2006 575 582
31. N. D'Ambrosi, P. Finocchi, S. Apolloni, M. Cozzolino, A. Ferri, and V. Padovano The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis J Immunol 183 2009 4648 4656
32. E. Daré, G. Schulte, O. Karovic, C. Hammarberg, and B.B. Fredholm Modulation of glial cell functions by adenosine receptors Physiol Behav 92 2007 15 20 (Pubitemid 47374251)
33. H.X. Deng, A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, and W.Y. Hung Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase Science 261 1993 1047 1051 (Pubitemid 23300865)
34. F. Di Virgilio, S. Ceruti, P. Bramanti, and M.P. Abbracchio Purinergic signalling in inflammation of the central nervous system Trends Neurosci 32 2009 79 87
35. F. Di Virgilio, J.M. Boeynaems, and S.C. Robson Extracellular nucleotides as negative modulators of immunity Curr Opin Pharmacol 9 2009 507 513
36. M. Diàz-Hernandez, M. Díez-Zaera, J. Sánchez- Nogueiro, R. Gómez-Villafuertes, J.M. Canals, and J. Alberch Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration FASEB J 23 2009 1893 1906
37. P.A. Dion, H. Daoud, and G.A. Rouleau Genetics of motor neuron disorders: New insights into pathogenic mechanisms Nat Rev Genet 10 2009 769 782
38. G. Dobrowolny, M. Augello, M. Molinaro, and A. Musarò Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model Neurol Res 30 2008 131 136 (Pubitemid 351768831)
39. L. Dupuis, and J.P. Loeffler Neuromuscular junction destruction during amyotrophic lateral sclerosis: Insights from transgenic models Curr Opin Pharmacol 9 2009 341 346
40. C. Escudero, P. Casanello, and L. Sobrevia Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia Placenta 29 2008 816 825
41. K. Färber, and H. Kettenmann Purinergic signaling and microglia Pflugers Arch 452 2006 615 621 (Pubitemid 44015096)
42. K. Färber, S. Markworth, U. Pannasch, C. Nolte, V. Prinz, and G. Kronenberg The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration Glia 56 2008 331 341
43. T.A. Ferguson, and L.B. Elman Clinical presentation and diagnosis of amyotrophic lateral sclerosis NeuroRehabilitation 22 2007 409 416
44. W. Fischer, and U. Krügel P2Y receptors: focus on structural, pharmacological and functional aspects in the brain Curr Med Chem 14 2007 2429 2455 (Pubitemid 47618033)
45. W. Fischer, K. Appelt, M. Grohmann, H. Franke, W. Nörenberg, and P. Illes Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat Neuroscience 160 2009 767 783
46. J.G. Fitz Regulation of cellular ATP release Trans Am Clin Climatol Assoc 118 2007 199 208
47. B.B. Fredholm Adenosine, an endogenous distress signal, modulates tissue damage and repair Cell Death Differ 14 2007 1315 1323 (Pubitemid 46965261)
48. S.A. Friedle, M.A. Curet, and J.J. Watters Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation Recent Pat CNS Drug Discov 5 2010 35 45
49. M. Gandelman, H. Peluffo, J.S. Beckman, P. Cassina, and L. Barbeito Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: Implications for amyotrophic lateral sclerosis J Neuroinflammation 7 2010 33
50. J.M. Garré, M.A. Retamal, P. Cassina, L. Barbeito, F.F. Bukauskas, and J.C. Sáez FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels Proc Natl Acad Sci U S A 107 2010 22659 22664
51. Y.H. Gong, A.S. Parsadanian, A. Andreeva, W.D. Snider, and J.L. Elliott Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration J Neurosci 20 2000 660 665 (Pubitemid 30225568)
52. M.M. Halassa, and P.G. Haydon Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior Annu Rev Physiol 72 2010 335 355
53. U.K. Hanisch, and H. Kettenmann Microglia: Active sensor and versatile effector cells in the normal and pathologic brain Nat Neurosci 10 2007 1387 1394 (Pubitemid 350014685)
54. G. Haskó, P. Pacher, E.S. Vizi, and P. Illes Adenosine receptor signaling in the brain immune system Trends Pharmacol Sci 26 2005 511 516 (Pubitemid 41338561)
55. J.S. Henkel, D.R. Beers, L. Siklos, and S.H. Appel The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS Mol Cell Neurosci 31 2006 427 437 (Pubitemid 43358017)
56. J.S. Henkel, D.R. Beers, W. Zhao, and S.H. Appel Microglia in ALS: The good, the bad, and the resting J Neuroimmune Pharmacol 4 2009 389 398
57. S. Hernández, A. Casanovas, L. Piedrafita, O. Tarabal, and J.E. Esquerda Neurotoxic species of misfolded SOD1G93A recognized by antibodies against the P2X4 subunit of the ATP receptor accumulate in damaged neurons of transgenic animal models of amyotrophic lateral sclerosis J Neuropathol Exp Neurol 69 2010 176 187
58. H. Ilieva, M. Polymenidou, and D.W. Cleveland Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond J Cell Biol 187 2009 761 772
59. K. Inoue Purinergic systems in microglia Cell Mol Life Sci 65 2008 3074 3080
60. K. Inoue, S. Koizumi, and M. Tsuda The role of nucleotides in the neuron-glia communication responsible for the brain functions J Neurochem 102 2007 1447 1458 (Pubitemid 47256211)
61. D. Jaarsma, E. Teuling, E.D. Haasdijk, C.I. De Zeeuw, and C.C. Hoogenraad Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice J Neurosci 28 2008 2075 2088 (Pubitemid 351317636)
62. L. Jiang, M. Bardini, A. Keogh, C.G. dos Remedios, and G. Burnstock P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium Int J Cardiol 98 2005 291 297 (Pubitemid 40431177)
63. T. Kawamata, H. Akiyama, T. Yamada, and P.L. McGeer Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue Am J Pathol 140 1992 691 707
64. B.S. Khakh, and G. Burnstock The double life of ATP Sci Am 301 84-90 2009 92
65. D. Kieran, B. Kalmar, J.R. Dick, J. Riddoch-Contreras, G. Burnstock, and L. Greensmith Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice Nat Med 10 2004 402 405 (Pubitemid 38508519)
66. M.C. Kiernan, S. Vucic, B.C. Cheah, M.R. Turner, A. Eisen, and O. Hardiman Amyotrophic lateral sclerosis Lancet 377 2011 942 955
67. A.E. King, M.A. Ackley, C.E. Cass, J.D. Young, and S.A. Baldwin Nucleoside transporters: From scavengers to novel therapeutic targets Trends Pharmacol Sci 27 2006 416 425 (Pubitemid 44051567)
68. L. Köles, Z. Gerevich, J.F. Oliveira, Z.S. Zadori, K. Wirkner, and P. Illes Interaction of P2 purinergic receptors with cellular macromolecules Naunyn Schmiedebergs Arch Pharmacol 377 2008 1 33 (Pubitemid 351253067)
69. J. Kuhle, R.L. Lindberg, A. Regeniter, M. Mehling, A.J. Steck, and L. Kappos Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis Eur J Neurol 16 2009 771 774
70. T.J. Kwiatkowski Jr., D.A. Bosco, A.L. Leclerc, E. Tamrazian, C.R. Vanderburg, and C. Russ Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis Science 323 2009 1205 1208
71. C. Lagier-Tourenne, M. Polymenidou, and D.W. Cleveland TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration Hum Mol Genet 19 2010 46 64
72. A.C. Lepore, B. Rauck, C. Dejea, A.C. Pardo, M.S. Rao, and J.D. Rothstein Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease Nat Neurosci 11 2008 1294 1301
73. M.M. Lino, C. Schneider, and P. Caroni Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease J Neurosci 22 2002 4825 4832 (Pubitemid 37465597)
74. Y. Liu, W. Hao, A. Dawson, S. Liu, and K. Fassbender Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2 J Biol Chem 284 2009 3691 3699
75. C.S. Lobsiger, S. Boillée, M. McAlonis-Downes, A.M. Khan, M.L. Feltri, and K. Yamanaka Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice Proc Natl Acad Sci U S A 106 2009 4465 4470
76. L.J. Martin Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis IDrugs 13 2010 568 580
77. H.R. Martinez, M.T. Gonzalez-Garza, J.E. Moreno-Cuevas, E. Caro, E. Gutierrez-Jimenez, and J.J. Segura Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients Cytotherapy 11 2009 26 34
78. C. Matute P2X7 receptors in oligodendrocytes: A novel target for neuroprotection Mol Neurobiol 38 2008 123 128
79. C. Matute Glutamate and ATP signalling in white matter pathology J Anat 2011 10.1111/j.1469-7580.2010.01339.x
80. A. Milane, C. Fernandez, L. Dupius, M. Buyse, J.P. Loeffler, and R. Farinotti P-glycoprotein expression and function are increased in animal model of amyotrophic lateral sclerosis Neurosci Lett 472 2010 166 170
81. T.M. Miller, S.H. Kim, K. Yamanaka, M. Hester, P. Umapathi, and H. Arnson Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis Proc Natl Acad Sci U S A 103 2006 19546 19551 (Pubitemid 46026068)
82. R.G. Miller, J.D. Mitchell, M. Lyon, and D.H. Moore Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst Rev 2007 CD001447
83. J. Mitchell, P. Paul, H.J. Chen, A. Morris, M. Payling, and M. Falchi Familial amyotrophic lateral sclerosis is associated with a mutation in d-amino acid oxidase Proc Natl Acad Sci U S A 107 2010 7556 7561
84. Y. Mizuno, K. Hasegawa, T. Kondo, S. Kuno, M. Yamamoto Japanese Istradefylline Study Group Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study Mov Disord 25 2010 1437 1443
85. J. Mojsilovic-Petrovic, G.B. Jeong, A. Crocker, A. Arneja, S. David, and D.S. Russell Protecting motor neurons from toxic insult by antagonism of adenosine A2A and Trk receptors J Neurosci 26 2006 9250 9263 (Pubitemid 44359851)
86. M. Nagai, D.B. Re, T. Nagata, A. Chalazonitis, T.M. Jessell, and H. Wichterle Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons Nat Neurosci 10 2007 615 622 (Pubitemid 46652435)
87. S. Naor, Z. Keren, T. Bronshtein, E. Goren, M. Machluf, and D. Melamed Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes J Neurol 256 2009 1228 1235
88. S. Omura Ivermectin: 25 years and still going strong Int J Antimicrob Agents 31 2008 91 98
89. D. Papadimitriou, V. Le Verche, A. Jacquier, B. Ikiz, S. Przedborski, and D.B. Re Inflammation in ALS and SMA: Sorting out the good from the evil Neurobiol Dis 37 2010 493 502
90. W. Peng, M.L. Cotrina, X. Han, H. Yu, L. Bekar, and L. Blum Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury Proc Natl Acad Sci U S A 106 2009 12489 12493
91. J.J. Perry, D.S. Shin, and J.A. Tainer Amyotrophic lateral sclerosis Adv Exp Med Biol 685 2010 9 20
92. J. Phukan Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis IDrugs 13 2010 482 496
93. J.M. Pocock, and H. Kettenmann Neurotransmitter receptors on microglia Trends Neurosci 30 2007 527 535 (Pubitemid 47513237)
94. H. Potschka Targeting regulation of ABC efflux transporters in brain diseases: A novel therapeutic approach Pharmacol Ther 125 2010 118 127
95. N.J. Press, and J.R. Fozard Progress towards novel adenosine receptor therapeutics gleaned from the recent patent literature Expert Opin Ther Pat 20 2010 987 1005
96. D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, and A. Hentati Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62 (Pubitemid 23087289)
97. J.D. Rothstein Current hypotheses for the underlying biology of amyotrophic lateral sclerosis Ann Neurol 65 Suppl. 1 2009 S3 S9
98. M. Sabatelli, F. Eusebi, A. Al-Chalabi, A. Conte, F. Madia, and M. Luigetti Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis Hum Mol Genet 18 2009 3997 4006
99. S.A. Sakowski, A.D. Schuyler, and E.L. Feldman Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis Amyotroph Lateral Scler 10 2009 63 73
100. S.A. Sargsyan, D.J. Blackburn, S.C. Barber, P.N. Monk, and P.J. Shaw Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1 Neuroreport 20 2009 1450 1455
101. K. Schicker, S. Hussl, G.K. Chandaka, K. Kosenburger, J.W. Yang, and M. Waldhoer A membrane network of receptors and enzymes for adenine nucleotides and nucleosides Biochim Biophys Acta 1793 2009 325 334
102. G. Siciliano, C. Carlesi, L. Pasquali, S. Piazza, S. Pietracupa, F. Fornai, S. Ruggirei, and L. Murri Clinical trials for neuroprotection in ALS CNS Neurol Disord Drug Targets 9 2010 305 313
103. V. Silani, C. Calzarossa, L. Cova, and N. Ticozzi Stem cells in amyotrophic lateral sclerosis: Motor neuron protection or replacement? CNS Neurol Disord Drug Targets 9 2010 314 324
104. N. Simola, M. Morelli, and A. Pinna Adenosine A2A receptor antagonists and Parkinson's disease: State of the art and future directions Curr Pharm Des 14 2008 1475 1489 (Pubitemid 351997813)
105. J. Sreedharan, I.P. Blair, V.B. Tripathi, X. Hu, C. Vance, and B. Rogelj TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis Science 319 2008 1668 1672 (Pubitemid 351432505)
106. T.W. Stone, S. Ceruti, and M.P. Abbracchio Adenosine receptors and neurological disease: Neuroprotection and neurodegeneration Handb Exp Pharmacol 193 2009 535 587
107. M.J. Strong The basic aspects of therapeutics in amyotrophic lateral sclerosis Pharmacol Ther 98 2003 379 414 (Pubitemid 36644160)
108. A. Surprenant, and R.A. North Signaling at purinergic P2X receptors Annu Rev Physiol 71 2009 333 359
109. T. Tateishi, R. Yamasaki, M. Tanaka, T. Matsushita, H. Kikuchi, and N. Isobe CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis J Neuroimmunol 222 2010 76 81
110. B.J. Turner, and K. Talbot Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS Prog Neurobiol 85 2008 94 134
111. P. Van Damme, and W. Robberecht Recent advances in motor neuron disease Curr Opin Neurol 22 2009 486 492
112. L. Van Den Bosch, and W. Robberecht Crosstalk between astrocytes and motor neurons: What is the message? Exp Neurol 211 2008 1 6
113. C. Vance, B. Rogelj, T. Hortobágyi, K.J. De Vos, A.L. Nishimura, and J. Sreedharan Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 Science 323 2009 1208 1211
114. A. Verkhratsky, O.A. Krishtal, and G. Burnstock Purinoceptors on neuroglia Mol Neurobiol 39 2009 190 208
115. C. Volonté, and N. D'Ambrosi Membrane compartments and purinergic signalling: The purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters FEBS J 276 2009 318 329
116. C. Volonté, S. Amadio, F. Cavaliere, N. D'Ambrosi, F. Vacca, and G. Bernardi Extracellular ATP and neurodegeneration Curr Drug Targets CNS Neurol Disord 2 2003 403 412
117. C. Volonté, S. Amadio, N. D'Ambrosi, M. Colpi, and G. Burnstock P2 receptor web: Complexity and fine-tuning Pharmacol Ther 112 2006 264 280 (Pubitemid 44301494)
118. C. Volonté, N. D'Ambrosi, and S. Amadio Protein cooperation: From neurons to networks Prog Neurobiol 86 2008 61 71
119. C. Volonté, S. Amadio, and N. D'Ambrosi Receptor webs: Can the chunking theory tell us more about it? Brain Res Rev 59 2008 1 8
120. L. Wang, K. Sharma, G. Grisotti, and R.P. Roos The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis Neurobiol Dis 35 2009 234 240
121. M.R. Wink, E. Braganhol, A.S. Tamajusuku, G. Lenz, L.F. Zerbini, and T.A. Libermann Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes Neuroscience 138 2006 421 432 (Pubitemid 43255555)
122. M. Wong, and L.J. Martin Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice Hum Mol Genet 19 2010 2284 2302
123. K. Yamanaka, S. Boillée, E.A. Roberts, M.L. Garcia, M. McAlonis-Downes, and O.R. Mikse Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice Proc Natl Acad Sci U S A 105 2008 7594 7599 (Pubitemid 351830063)
124. K. Yamanaka, S.J. Chun, S. Boillée, N. Fujimori-Tonou, H. Yamashita, and D.H. Gutmann Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis Nat Neurosci 11 2008 251 253 (Pubitemid 351311795)
125. Y. Yang, O. Gozen, A. Watkins, I. Lorenzini, A. Lepore, and Y. Gao Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1 Neuron 61 2009 880 894
126. Y. Yiangou, P. Facer, P. Durrenberger, I.P. Chessell, A. Naylor, and C. Bountra COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurol 6 2006 12
127. W. Zhao, D.R. Beers, J.S. Henkel, W. Zhang, M. Urushitani, and J.P. Julien Extracellular mutant SOD1 induces microglial-mediated motoneuron injury Glia 58 2010 231 243
128. Z. Zhong, R. Deane, Z. Ali, M. Parisi, Y. Shapovalov, and M.K. O'Banion ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration Nat Neurosci 11 2008 420 422 (Pubitemid 351441888)
129. H. Zimmermann Ectonucleotidases in the nervous system Novartis Found Symp 276 2006 113 128